Clinical Assessment & Protocol
Typical Presentation (HPI)
EN: Patient presents with sudden loss of thrill and audible bruit in the AVF. Reports no recent trauma or hypotension. History of progressive access dysfunction, including prolonged bleeding post-dialysis and elevated venous pressures during recent sessions. No signs of infection or hematoma. AR: يعاني المريض من فقدان مفاجئ للرعشة (Thrill) والصوت الوعائي (Bruit) في وصلة الشريان الوريدي (AVF). لا يوجد تاريخ لصدمات أو انخفاض في ضغط الدم. يشير التاريخ المرضي إلى خلل تدريجي في الوصلة، بما في ذلك استمرار النزيف بعد الغسيل الكلوي وارتفاع الضغط الوريدي في الجلسات الأخيرة. لا توجد علامات عدوى أو ورم دموي.
General Examination
EN: AVF site inspection reveals no erythema, warmth, or purulent drainage. Palpation confirms absence of thrill. Auscultation confirms absence of bruit. Distal pulses are intact. No signs of limb edema or venous congestion. AR: فحص موقع وصلة الشريان الوريدي لا يظهر احمراراً، أو حرارة، أو إفرازات صديدية. الجس يؤكد غياب الرعشة (Thrill). التسمع يؤكد غياب الصوت الوعائي (Bruit). النبضات الطرفية سليمة. لا توجد علامات وذمة في الطرف أو احتقان وريدي.
Treatment Protocol
EN: Immediate referral to Interventional Radiology or Vascular Surgery for urgent thrombectomy/thrombolysis. Initiate systemic anticoagulation if not contraindicated. Schedule urgent dialysis via temporary central venous catheter (CVC) to prevent uremic complications. AR: إحالة فورية إلى قسم الأشعة التداخلية أو جراحة الأوعية الدموية لإجراء استئصال الجلطة أو إذابتها بشكل عاجل. البدء في مضادات التخثر الجهازية إذا لم تكن هناك موانع. جدولة غسيل كلوي عاجل عبر قسطرة وريدية مركزية مؤقتة (CVC) لمنع مضاعفات اليوريميا.
Patient Education
EN: Your AVF has clotted, requiring urgent medical intervention to restore blood flow. Do not apply pressure or heat to the site. Monitor for signs of infection (fever, redness, pain). You will require a temporary catheter for dialysis until the fistula is successfully repaired. AR: لقد تعرضت وصلة الشريان الوريدي للجلطة، مما يتطلب تدخلاً طبياً عاجلاً لاستعادة تدفق الدم. لا تضع ضغطاً أو حرارة على الموقع. راقب علامات العدوى (حمى، احمرار، ألم). ستحتاج إلى قسطرة مؤقتة للغسيل الكلوي حتى يتم إصلاح الوصلة بنجاح.
Systemic & Specialized Examinations
EN: Regular heart rate and rhythm. No murmurs, rubs, or gallops. No jugular venous distension. Blood pressure stable. No signs of volume overload or acute heart failure secondary to access thrombosis. AR: معدل ضربات القلب ونظمه منتظم. لا توجد لغط أو احتكاك أو أصوات إضافية. لا يوجد تمدد في الوريد الوداجي. ضغط الدم مستقر. لا توجد علامات زيادة في حجم السوائل أو فشل قلب حاد ثانوي لجلطة الوصلة.
EN: Abdomen soft, non-tender, non-distended. Bowel sounds present. No hepatosplenomegaly. No clinical evidence of uremic gastropathy or acute GI distress related to current access failure. AR: البطن لين، غير مؤلم، وغير منتفخ. أصوات الأمعاء مسموعة. لا يوجد تضخم في الكبد أو الطحال. لا توجد أدلة سريرية على اعتلال المعدة اليوريمي أو ضائقة هضمية حادة مرتبطة بفشل الوصلة الحالي.
1. Executive Overview: Understanding AVF Thrombosis
An Arteriovenous Fistula (AVF) is the "gold standard" vascular access for patients undergoing long-term hemodialysis. It is a surgically created connection between an artery and a vein, designed to provide high-flow access for blood purification. However, Arteriovenous Fistula (AVF) Thrombosis (ICD-10: T82.868A) represents the most common cause of access failure.
Thrombosis occurs when a blood clot forms within the lumen of the fistula, obstructing blood flow. This is not merely a localized vascular event; it is a clinical emergency for the dialysis patient, as it necessitates immediate intervention to preserve the access and maintain the patient’s renal replacement therapy schedule. Understanding the interplay between systemic CKD complications—such as uremia, mineral bone disorder, and hemodynamic instability—is essential for the nephrology team to mitigate the risk of thrombosis.
2. Pathophysiology, Etiology, and Risk Factors
The formation of a thrombus in an AVF is rarely an isolated incident. It is usually the culmination of stenosis (narrowing), which creates turbulent flow, endothelial injury, and a pro-thrombotic environment.
The Mechanism of Failure
- Intimal Hyperplasia: The primary driver of stenosis. High shear stress at the venous anastomosis triggers a proliferative response, narrowing the vessel.
- Hemodynamic Alterations: Reduced flow rates (Qb) lead to stasis, which promotes fibrin deposition and eventual total occlusion.
- Systemic CKD Milieu: Patients with advanced CKD exhibit a state of chronic inflammation, platelet dysfunction, and altered coagulation factors, all of which lower the threshold for thrombus formation.
Risk Factors
- Anatomical Factors: Small vessel caliber, high-pressure zones, and previous access trauma.
- Systemic Factors: Hypotension during hemodialysis (leading to hypoperfusion of the fistula), hypercoagulable states, and poor glycemic control in diabetic nephropathy.
- Mineral Bone Disorder (CKD-MBD): Dysregulated calcium and phosphate levels can lead to vascular calcification, which stiffens the vessel walls and promotes stenosis.
3. Signs, Symptoms, and Clinical Presentation
Early detection is paramount. Patients and clinical staff should be trained to perform daily "Look, Listen, and Feel" assessments.
- Loss of Thrill and Bruit: The most sensitive sign. A silent fistula or one lacking the characteristic palpable vibration indicates potential thrombosis.
- Physical Changes: Edema of the extremity, collateral vein development (indicating proximal obstruction), or a firm, cord-like sensation upon palpation.
- Dialysis-Specific Signs: Difficulty in cannulation, high venous pressures during treatment, or recurrent clotting in the dialysis circuit.
4. Diagnostic Evaluation and Workup
When thrombosis is suspected, a standardized diagnostic pathway is mandatory to determine whether the fistula is salvageable.
Diagnostic Modalities
| Modality | Clinical Utility |
|---|---|
| Physical Exam | Initial assessment; loss of thrill/bruit is definitive. |
| Duplex Ultrasound | First-line imaging; assesses flow velocity and identifies anatomical stenosis. |
| Fistulogram (Angiography) | The gold standard for mapping the anatomy and guiding intervention. |
| Laboratory Workup | Assessment of inflammatory markers, coagulation profile, and renal function. |
Renal Context: The Big Picture
While the AVF is the focus, the nephrologist must maintain a holistic view of the patient’s renal status:
* eGFR/Creatinine Trends: A sudden decline in dialysis efficiency (Kt/V) due to thrombosis can lead to acute uremic symptoms (nausea, pericarditis, encephalopathy).
* Nephrotic vs. Nephritic considerations: While AVF thrombosis is vascular, patients with underlying glomerulonephritis may have higher fibrinogen levels, increasing thrombotic risk.
* Biopsy Implications: If the patient has a failing transplant or native kidney, clinicians must evaluate if the fistula failure is secondary to systemic vasculitis or chronic rejection.
5. Therapeutic Interventions
Management of AVF thrombosis is time-sensitive. The goal is "access salvage."
Surgical and Endovascular Interventions
- Pharmacomechanical Thrombectomy: Using specialized catheters to mechanically break the clot while infusing thrombolytic agents (e.g., tPA).
- Percutaneous Transluminal Angioplasty (PTA): Used to treat the underlying stenosis that caused the thrombosis.
- Surgical Revision: If endovascular methods fail, a surgeon may perform a thrombectomy or create a new anastomosis (revision).
Pharmacotherapy
- Antiplatelet Agents: Low-dose aspirin is often used for primary prophylaxis.
- Anticoagulation: In specific high-risk cases, warfarin or DOACs may be considered, though bleeding risks must be carefully weighed against the benefit of access patency.
Lifestyle and Management
- Blood Pressure Control: Maintaining adequate mean arterial pressure to ensure fistula perfusion without inducing hypertension.
- Monitoring: Regular surveillance of access flow (Qa) measurements every 3 months.
6. Frequently Asked Questions (FAQ)
1. Is AVF thrombosis a medical emergency?
Yes. If left untreated, the access will likely require surgical replacement. Prompt intervention can often salvage the fistula within 24–48 hours.
2. Can I prevent AVF thrombosis?
Regular exercise, avoiding blood pressure cuffs on the access arm, and monitoring the "thrill" daily are the best preventative measures.
3. What is the role of KDIGO guidelines in fistula care?
KDIGO provides clinical practice guidelines for vascular access, emphasizing the "Fistula First" initiative and standardized monitoring protocols to reduce thrombotic events.
4. How does CKD-MBD contribute to my fistula failing?
High phosphate levels promote vascular calcification. This makes the fistula vessels less compliant, increasing the risk of stenosis and subsequent clotting.
5. Will I need surgery if my fistula clots?
Not always. Many thromboses can be treated successfully in an interventional radiology suite using minimally invasive endovascular techniques.
6. How often should my fistula be monitored?
Clinically, every dialysis session. Instrumentally, surveillance of access flow (Qa) should occur quarterly to identify stenosis before it leads to thrombosis.
7. Does my kidney function (eGFR) affect fistula clotting?
Indirectly, yes. As renal function declines (stages 4-5), systemic inflammation and metabolic disturbances increase, which can predispose the blood to hypercoagulability.
8. What are the symptoms of a "failing" fistula?
Increased venous pressure during dialysis, prolonged bleeding after needle removal, and a change in the sound (bruit) of the fistula.
9. Can I still have dialysis if my fistula is thrombosed?
You will likely require a temporary central venous catheter (CVC) as a bridge until the AVF is repaired or a new access is created.
10. What is the link between nephrotic syndrome and AVF thrombosis?
Nephrotic syndrome causes a hypercoagulable state due to the loss of antithrombin III in the urine, which significantly increases the risk of both venous and arterial thrombosis, including within the AVF.
Disclaimer: This content is for educational purposes and does not replace professional medical advice. If you suspect an AVF thrombosis, contact your nephrology care team immediately.
